Tesamorelin is marketed as Egrifta SV (approved November 2010) for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. In clinical trials, it reduced visceral fat by ...
View full compound profile →Vendors stocking
17
across 5 countries
Total listings
21
18 in stock
Price range
£21.99–£136.00
Median price per mg
£9.50
Most common size
10mg
9 listings
Forms available
vial
Stock health
86%
16 vendors · 18 listings
2mg
2 listings
Avg price: £27.48
Avg per mg: £13.74
5mg
3 listings
Avg price: £41.65
Avg per mg: £8.33
10mg
8 listings
Avg price: £97.36
Avg per mg: £9.74
This compound is an approved pharmaceutical. Prices shown are from research-grade vendors and may differ from prescription pricing. Consult a healthcare professional before use.
Prices last updated: 15 May 2026
Data sourced from 17 vendor websites across 5 countries
